BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 30649299)

  • 1. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
    Damania B; Münz C
    FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune control of oncogenic γ-herpesviruses.
    Jung J; Münz C
    Curr Opin Virol; 2015 Oct; 14():79-86. PubMed ID: 26372881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections.
    Münz C
    J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
    Böni M; Rieble L; Münz C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis.
    Hassan STS; Šudomová M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic γ-Herpesviruses.
    Münz C
    Adv Exp Med Biol; 2020; 1225():127-135. PubMed ID: 32030652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections.
    Münz C
    Front Immunol; 2020; 11():581419. PubMed ID: 33013936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses.
    Münz C
    Viruses; 2021 May; 13(5):. PubMed ID: 34066671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.
    Pinzone MR; Berretta M; Cacopardo B; Nunnari G
    Semin Oncol; 2015 Apr; 42(2):258-71. PubMed ID: 25843730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancers associated with human gammaherpesviruses.
    Wen KW; Wang L; Menke JR; Damania B
    FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components.
    Münz C
    Front Immunol; 2018; 9():238. PubMed ID: 29483919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.
    Taylor GS; Blackbourn DJ
    Cancer Lett; 2011 Jun; 305(2):263-78. PubMed ID: 21470769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.
    McHugh D; Caduff N; Murer A; Engelmann C; Deng Y; Zdimerova H; Zens K; Chijioke O; Münz C
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180296. PubMed ID: 30955487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
    Münz C
    Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
    Latour S; Fischer A
    Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS-Associated Malignancies.
    Vangipuram R; Tyring SK
    Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-herpesvirus neoplasia: a growing role for COX-2.
    Shelby BD; Nelson A; Morris C
    Microsc Res Tech; 2005 Nov; 68(3-4):120-9. PubMed ID: 16276519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
    Katano H
    Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.